EVALUATION OF NEW HDACs INHIBITORS OVER TUMORAL AND NORMAL CELL LINES.

被引：0
|
作者：
Jimenez, E. M. [1 ]
Munoz, C. T. [2 ]
Percino, T. M. [2 ]
机构：
[1] Inst Politecn Nacl, ESM CINVESTAV, Mexico City, DF, Mexico
[2] Inst Politecn Nacl, Mexico City, DF, Mexico
来源：
MOLECULAR BIOLOGY OF THE CELL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P304
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Detection of an MDS1-EVI1 fusion transcript in normal tissues and in leukemic cell lines.
    Sigurdsson, F
    Lopingco, T
    Perkins, AS
    Berliner, N
    BLOOD, 1995, 86 (10) : 2953 - 2953
  • [42] Molecular characterization and gefitinib (IRESSA) sensitivity of a panel of 12 new HNSCC cell lines.
    Sebastian, S
    Azzariti, A
    Porcelli, L
    Simone, GM
    Tommasino, M
    Paradiso, A
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9045S - 9045S
  • [43] Detection of an MDS1-EVI1 fusion transcript in normal tissues and in leukemic cell lines.
    Sigurdsson, F
    Lopingco, T
    Perkins, AS
    Berliner, N
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A213 - A213
  • [44] Ultrastructural study on the effect of a new compound with antitumor activity potentially on tumor cell lines.
    Reyes, J
    Aleman, MR
    Menendez, I
    de la Rosa, MC
    Abrahantes, MC
    ELECTRON MICROSCOPY 1998, VOL 4: BIOLOGICAL SCIENCES, 1998, : 845 - 846
  • [45] Evaluation of in vitro synergistic antitumor activity of Enzastaurin and Alimta® against thyroid cancer cell lines.
    Oberschmidt, O
    Eismann, U
    Schulz, L
    Struck, S
    Blatter, J
    Lahn, MM
    Ma, D
    Hanauske, AR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9033S - 9034S
  • [46] Synergistic combinations of EGFR tyrosine kinase inhibitors and conventional chemotherapy: in vitro median effect analysis in cell lines.
    Budman, DR
    Calabro, A
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S131 - S131
  • [47] Transcription therapy for cancer: Effects of histone deacetylase (HDAC) inhibitors on proliferation, apoptosis and differentiation of leukemic cell lines.
    He, LZ
    Tolentino, T
    Warrell, RP
    Zelent, A
    Rifkind, RA
    Marks, PA
    Richon, VM
    Pandolfi, PP
    BLOOD, 1998, 92 (10) : 510A - 510A
  • [48] Effects of protein kinase inhibitors and oncogenes on galectin-3 expression in monocyte-macrophage cell lines.
    Kim, K
    Mayer, EP
    Legrand, A
    Nachtigal, M
    FASEB JOURNAL, 1998, 12 (04): : A482 - A482
  • [49] Effect of Androgen Receptor (AR) Expression Levels and Proteasome Inhibitors on AR Activity in Prostate Cancer Cell lines.
    Macaulay, D.
    Taylor, T.
    Williams, E.
    Stone, J.
    Peterson, D.
    Kelly-Brown, C.
    Carson, L.
    Regisford, G. C.
    Nakka, M.
    Bingman, W. E., III
    Weigel, N. L.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [50] Differences in Angiotensin-(1-7)/alamandine-mediated Signaling in Tumoral and Normal Cell Lines
    Sampaio, Walkyria O.
    Oliveira, Marilene Luzia
    Silva, Felipe A.
    Silva, Leticia B.
    Etelvino, Gisele M.
    Passos-Silva, Danielle G.
    Santos, Robson A.
    HYPERTENSION, 2016, 68
12345